The effect of smoking on the treatment outcome in patients with pulmonary tuberculosis: A prospective cohort study Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
Factors associated to pulmonary tuberculosis sequelae: A pilot study Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
First data about the efficacy of moxifloxacin in the treatment of pulmonary tuberculosis – a prospective, randomised study versus INH Source: Annual Congress 2003 - Management of tuberculosis and tubercular infection - old and new considerations Year: 2003
Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study Source: Eur Respir J 2001; 18: 369-375 Year: 2001
Predicting pulmonary tuberculosis in immigrants: a retrospective cohort study Source: ERJ Open Res, 4 (2) 00170-2017; 10.1183/23120541.00170-2017 Year: 2018
Late Breaking Abstract: High-dose vitamin D3 during intensive phase treatment of pulmonary tuberculosis: A double-blind randomised controlled trial Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010
Biomarkers for risk of developing active tuberculosis in contacts of TB patients: a prospective cohort study Source: Eur Respir J 2015; 46: 1095-1103 Year: 2015
Short term treatment response in pulmonary sarcoidosis – a prospective study Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021
Rare forms of tuberculosis – a retrospective study Source: Eur Respir J 2007; 30: Suppl. 51, 88s Year: 2007
Time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis: a prospective cohort study from urban China Source: Eur Respir J , 49 (3) 1601558; DOI: 10.1183/13993003.01558-2016 Year: 2017
Use of quantiferon-TB in tube in the diagnosis of active tuberculosis: A multicenter study Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010
Vitamin D as a supplementary agent in the treatment of pulmonary tuberculosis: A systematic review and meta-analysis of randomized controlled trials Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency Year: 2013
A prospective study of prevalence of adverse drug reactions to the short course anti-tuberculosis regimen in Korea Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control Year: 2007
The treatment outcomes of isoniazid resistant tuberculosis: Multicenter and retrospective study in South Korea Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010
Subclinical tuberculosis disease and its treatment outcomes: a prospective cohort study in South Korea Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020
Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea Source: Eur Respir J, 51 (3) 1702467; 10.1183/13993003.02467-2017 Year: 2018
Comparison of Interferon gamma-1b (IFN-γ)and colcicine in the treatment of Idiopathic pulmonary fibrosis: preliminary results of a prospective, multicenter randomised study Source: Eur Respir J 2002; 20: Suppl. 38, 599s Year: 2002
Patterns of drug resistance in pulmonary tuberculosis: results of an open prospective study in Tanta, Egypt Source: Eur Respir J 2001; 18: Suppl. 33, 314s Year: 2001